Drug
Asp6294
Asp6294: highest development phase Phase 2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASP6294 NCT03282318 | Phase 2 | Bladder Pain Syndrome |
Latest
No recent events.
Follow Asp6294 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.